Hot Investor Mandate 3: Pharma Firm Seeks Novel Drugs in Blood Cancers, Pediatric Diseases and Sleep Disorders

20 Apr

A pharma firm headquartered in Europe, with offices in the U.S. and across Europe, forms in-licensing relationships and partnerships with development-stage pharmaceutical companies. The firm is open to partnering with companies globally.

The firm is focused on hematology-oncology, and sleep disorders. The firm is also interested in reviewing assets in pediatric oncology, niche areas of CNS and other rare disorders, particularly pediatric diseases. The firm generally prefers that assets that have obtained proof of concept in humans, but may look at earlier stage opportunities in the firm’s key areas of hematology-oncology or sleep disorders.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: